Acupuncture provides pain relief and improves function for people with osteoarthritis of the knee and serves as an effective complement to standard care.
2004 Press Releases
The National Institutes of Health (NIH) is conducting a nationwide study on the safety and effectiveness of chelation therapy, an investigational treatment for people with heart disease.
NCCAM will host its Distinguished Lecture in the Science of Complementary and Alternative Medicine by Steven Kliewer, Ph.D., of The University of Texas Southwestern Medical Center at Dallas, on “Reverse Herbology: Predicting and Preventing Adverse Herb-Drug Interactions.”
NCCAM announces six major awards to expand the scope and impact of its research centers portfolio. These new research centers continue NCCAM’s commitment to enhance CAM research capacity by funding centers at institutions across the country.
NCCAM’s National Advisory Council (NACCAM) welcomed six new members today. Appointed by Health and Human Services Secretary Tommy G. Thompson, each new council member will serve a 4-year term, replacing members who have completed their service.
According to a new nationwide government survey, 36 percent of U.S. adults aged 18 years and over use some form of complementary and alternative medicine (CAM).
NCCAM and the National Center for Health Statistics of the Centers for Disease Control and Prevention will hold a telephone briefing to discuss the findings of a new nationwide survey that reveals the extensive use of complementary and alternative medicine (CAM) in the United States.
NCCAM will host a Strategic Planning Stakeholder Forum seeking public input for its second 5-year strategic plan. The Center is interested in hearing from a variety of stakeholders about their views of the opportunities, challenges, and areas of emphasis in research concerning complementary and alternative medicine.
Bruce McEwen, Ph.D., of The Rockefeller University, will present “From Molecules to Mind: Stress, Individual Differences, and the Social Environment” on Wednesday, March 31, 2004, from noon to 1:00 p.m.
NCCAM will host the first of two Strategic Planning Stakeholder Forums seeking public input for its second 5-year strategic plan. The Center is interested in hearing from a variety of stakeholders about their views of the opportunities, challenges, and areas of emphasis in research concerning complementary and alternative medicine.
The Food and Drug Administration (FDA) today issued a final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids (ephedra) because such supplements present an unreasonable risk of illness or injury. The rule will become effective 60 days from the date of publication.
NCCAM celebrates its 5th anniversary by launching its second strategic planning effort. The year-long effort invites input from the public, researchers, health care professionals, NCCAM staff, and others with an interest in research on CAM.